PMC6349596_01
Radiation dose distribution to the initial comprehensive volume after hyperfractionation was prescribed. (A) Representative axial slice and (B) representative sagittal slice.
gr1.jpg
PMC6349596_01_gr1.jpg
fig1
EBRT was prescribed to both tumor beds, ipsilateral facial, periparatoid, and levels IB-V neck lymphatics (Figure 1, Figure 2).
Radiation dose distribution to the initial comprehensive volume after hyperfractionation was prescribed. Digitally reconstructive radiograph. Pacemaker is represented in pink.
gr2.jpg
PMC6349596_01_gr2.jpg
fig2
EBRT was prescribed to both tumor beds, ipsilateral facial, periparatoid, and levels IB-V neck lymphatics (Figure 1, Figure 2).
Patient receiving hyperthermia treatment. The patient had a robust response to altered treatment and demonstrated complete response at 6 weeks posttherapy.
gr3.jpg
PMC6349596_01_gr3.jpg
fig3
Hyperfractionated EBRT was paired with concurrent twice-weekly ETT (Fig 3).
Superficial temple lesions mid-treatment recurrence (A), one (B) and three (C) months post-treatment.
gr4.jpg
PMC6349596_01_gr4.jpg
fig4
At subsequent follow-up, the patient had no further superficial or nodal recurrence or associated subacute/late toxicity (Fig 4).